576 related articles for article (PubMed ID: 31328444)
21. The Effect of Stigma on Family Planning and HIV Pre-exposure Prophylaxis Decisions of Young Women Accessing Post-Abortion Care in Kenya.
Zia Y; Etyang L; Mwangi M; Njiru R; Mogaka F; June L; Njeru I; Makoyo J; Kimani S; Ngure K; Wanyama I; Bukusi E; Nyerere B; Nyamwaro C; Mugo N; Heffron R;
AIDS Behav; 2024 Jun; 28(6):1834-1844. PubMed ID: 38451448
[TBL] [Abstract][Full Text] [Related]
22. Factors that influence adolescent girls and young women's re-initiation or complete discontinuation from daily oral PrEP use: a qualitative study from Eastern Cape Province, South Africa.
de Vos L; Mudzingwa EK; Fynn L; Atujuna M; Mugore M; Gandhi M; Celum C; Hosek S; Bekker LG; Daniels J; Medina-Marino A
J Int AIDS Soc; 2023 Sep; 26(9):e26175. PubMed ID: 37758649
[TBL] [Abstract][Full Text] [Related]
23. Stigma in the health clinic and implications for PrEP access and use by adolescent girls and young women: conflicting perspectives in South Africa.
Nyblade L; Ndirangu JW; Speizer IS; Browne FA; Bonner CP; Minnis A; Kline TL; Ahmed K; Howard BN; Cox EN; Rinderle A; Wechsberg WM
BMC Public Health; 2022 Oct; 22(1):1916. PubMed ID: 36242000
[TBL] [Abstract][Full Text] [Related]
24. Multi-level Interventions to Promote Oral Pre-exposure Prophylaxis Use Among Adolescent Girls and Young Women: a Review of Recent Research.
Irungu E; Khoza N; Velloza J
Curr HIV/AIDS Rep; 2021 Dec; 18(6):490-499. PubMed ID: 34719745
[TBL] [Abstract][Full Text] [Related]
25. Continued attendance in a PrEP program despite low adherence and non-protective drug levels among adolescent girls and young women in Kenya: Results from a prospective cohort study.
Tapsoba JD; Cover J; Obong'o C; Brady M; Cressey TR; Mori K; Okomo G; Kariithi E; Obanda R; Oluoch-Madiang D; Chen YQ; Drain P; Duerr A
PLoS Med; 2022 Sep; 19(9):e1004097. PubMed ID: 36095005
[TBL] [Abstract][Full Text] [Related]
26. PrEP implementation research in Africa: what is new?
Cowan FM; Delany-Moretlwe S; Sanders EJ; Mugo NR; Guedou FA; Alary M; Behanzin L; Mugurungi O; Bekker LG
J Int AIDS Soc; 2016; 19(7(Suppl 6)):21101. PubMed ID: 27760680
[TBL] [Abstract][Full Text] [Related]
27. Early implementation learnings on acceptability and feasibility of "V": a multi-level PrEP intervention designed with and for adolescent girls and young women in Zimbabwe.
Sisimayi T; Nhamo D; Chatora K; Chapwanya G; Mawoyo T; Ncube G; Bruns C; Harris EL; Shelley KD
Health Res Policy Syst; 2023 Oct; 21(1):101. PubMed ID: 37784195
[TBL] [Abstract][Full Text] [Related]
28. How a menu of adherence support strategies facilitated high adherence to HIV prevention products among adolescent girls and young women in sub-Saharan Africa: a mixed methods analysis.
Roberts ST; Mancuso N; Williams K; Nabunya HK; Mposula H; Mugocha C; Mvinjelwa P; Garcia M; Szydlo DW; Soto-Torres L; Ngure K; Hosek S
J Int AIDS Soc; 2023 Nov; 26(11):e26189. PubMed ID: 37936551
[TBL] [Abstract][Full Text] [Related]
29. Preference for novel biomedical HIV pre-exposure prophylaxis methods among adolescent girls and young women in Kampala, Uganda: a mixed methods study.
Mayanja Y; Kayesu I; Kamacooko O; Lunkuse JF; Muturi-Kioi V; Price M; Kosidou K; Ekström AM
Front Public Health; 2024; 12():1369256. PubMed ID: 38846614
[TBL] [Abstract][Full Text] [Related]
30. Adaptive HIV pre-exposure prophylaxis adherence interventions for young South African women: Study protocol for a sequential multiple assignment randomized trial.
Velloza J; Poovan N; Ndlovu N; Khoza N; Morton JF; Omony J; Mkwanazi E; Grabow C; Donnell D; Munthali R; Baeten JM; Hosek S; Celum C; Delany-Moretlwe S
PLoS One; 2022; 17(4):e0266665. PubMed ID: 35417485
[TBL] [Abstract][Full Text] [Related]
31. Perceptions of and interest in HIV pre-exposure prophylaxis use among adolescent girls and young women in Lilongwe, Malawi.
Maseko B; Hill LM; Phanga T; Bhushan N; Vansia D; Kamtsendero L; Pettifor AE; Bekker LG; Hosseinipour MC; Rosenberg NE
PLoS One; 2020; 15(1):e0226062. PubMed ID: 31929547
[TBL] [Abstract][Full Text] [Related]
32. Feasibility and acceptability of peer-delivered HIV self-testing and PrEP for young women in Kampala, Uganda.
Nakalega R; Mukiza N; Menge R; Kizito S; Babirye JA; Kuteesa CN; Mawanda D; Mulumba E; Nabukeera J; Ggita J; Nakanjako L; Akello C; Mirembe BG; Lukyamuzi Z; Nakaye C; Kataike H; Maena J; Etima J; Nabunya HK; Biira F; Nagawa C; Heffron R; Celum C; Gandhi M; Mujugira A
BMC Public Health; 2023 Jun; 23(1):1163. PubMed ID: 37322510
[TBL] [Abstract][Full Text] [Related]
33. From policy to practice: uptake of pre-exposure prophylaxis among adolescent girls and young women in United States President's Emergency Plan for AIDS Relief-supported countries, 2017-2020.
Patel P; Sato K; Bhandari N; Kanagasabai U; Schelar E; Cooney C; Eakle R; Klucking S; Toiv N; Saul J;
AIDS; 2022 Jun; 36(Suppl 1):S15-S26. PubMed ID: 35766572
[TBL] [Abstract][Full Text] [Related]
34. Key influences on the decision to initiate PrEP among adolescent girls and young women within routine maternal child health and family planning clinics in Western Kenya.
Rogers Z; Pintye J; Kinuthia J; O'Malley G; Abuna F; Escudero J; Mugambi M; Awuor M; Dollah A; Dettinger JC; Kohler P; John-Stewart G; Beima-Sofie K
AIDS Care; 2022 Mar; 34(3):363-370. PubMed ID: 34543077
[TBL] [Abstract][Full Text] [Related]
35. Alignment of PrEP adherence with periods of HIV risk among adolescent girls and young women in South Africa and Zimbabwe: a secondary analysis of the HPTN 082 randomised controlled trial.
Velloza J; Donnell D; Hosek S; Anderson PL; Chirenje ZM; Mgodi N; Bekker LG; Marzinke MA; Delany-Moretlwe S; Celum C
Lancet HIV; 2022 Oct; 9(10):e680-e689. PubMed ID: 36087612
[TBL] [Abstract][Full Text] [Related]
36. HIV prevention at drug shops: awareness and attitudes among shop dispensers and young women about oral pre-exposure prophylaxis and the dapivirine ring in Shinyanga, Tanzania.
Tubert J; Packel L; Hunter LA; Mfaume R; Njau P; Ramadhani AA; Liu JX; McCoy SI
AIDS Res Ther; 2021 Apr; 18(1):21. PubMed ID: 33902623
[TBL] [Abstract][Full Text] [Related]
37. Strengthening health system's capacity for pre-exposure prophylaxis for adolescent girls and young women and adolescent boys and young men in South Africa (SHeS'Cap-PrEP): Protocol for a mixed methods study in KwaZulu-Natal, South Africa.
Nicol E; Ramraj T; Hlongwa M; Basera W; Jama N; Lombard C; McClinton-Appollis T; Govindasamy D; Pass D; Funani N; Aheron S; Paredes-Vincent A; Drummond J; Cheyip M; Dladla S; Bedford J; Mathews C
PLoS One; 2022; 17(3):e0264808. PubMed ID: 35298487
[TBL] [Abstract][Full Text] [Related]
38. An individually randomized controlled trial of a mother-daughter HIV/STI prevention program for adolescent girls and young women in South Africa: IMARA-SA study protocol.
Donenberg GR; Atujuna M; Merrill KG; Emerson E; Ndwayana S; Blachman-Demner D; Bekker LG
BMC Public Health; 2021 Sep; 21(1):1708. PubMed ID: 34544403
[TBL] [Abstract][Full Text] [Related]
39. The influence of HIV-related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study.
Velloza J; Khoza N; Scorgie F; Chitukuta M; Mutero P; Mutiti K; Mangxilana N; Nobula L; Bulterys MA; Atujuna M; Hosek S; Heffron R; Bekker LG; Mgodi N; Chirenje M; Celum C; Delany-Moretlwe S;
J Int AIDS Soc; 2020 Mar; 23(3):e25463. PubMed ID: 32144874
[TBL] [Abstract][Full Text] [Related]
40. Uptake of and adherence to oral pre-exposure prophylaxis among adolescent girls and young women at high risk of HIV-infection in Kampala, Uganda: A qualitative study of experiences, facilitators and barriers.
Kayesu I; Mayanja Y; Nakirijja C; Machira YW; Price M; Seeley J; Siu G
BMC Womens Health; 2022 Nov; 22(1):440. PubMed ID: 36357920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
